RxDoctor Payments Data

Hunaldo Villalobos, MD

Neurological Surgery · Orlando, FLNPI 1457338949

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $504,257 of the $516,554 with a category attached, or 97.6%. Captiva Spine Inc accounts for 94.4% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $129,725, 2.4 times the $53,661 reported in 2019. Among neurological surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$516,554in general payments, 2019–2025

Across 134 payments — averaging $3854.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Captiva Spine Inc$488K
  • Orthofix Medical, Inc.$7K
  • Novapproach Spine, LLC$6K
  • LEM Surgical Inc.$6K
  • Xenix Medical LLC$4K
  • Medtronic$2K
  • plus $3K from 10 others

What the payments were for

  • Consulting fees$504,25798%
  • Speaking & faculty fees$2,5000%
  • Travel & lodging$4,0771%
  • Food & beverage$5,7051%
  • Education$150%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$516,554 in reported general payments places this provider in the 95th percentile of 556 neurological surgery providers in Florida.

See all neurological surgery providers in Florida

Medicare billing

Part B allowed, 2024
$172,335
Medicare patients
197
Services billed
446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TymlosAbaloparatide30$83,743
ForteoTeriparatide15$64,387
Naproxen117$779
Cyclobenzaprine Hcl167$665
Gabapentin102$631
Pregabalin13$550
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen56$486
Methylprednisolone53$349
Tramadol Hcl43$121
Ibuprofen13$93
Meloxicam22$43

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Radius Health, Inc.Tymlos$15$83,74330 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 556 neurological surgery providers in Florida.

Other neurological surgery in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →